Alanine, ethyl ester (9CI), with the CAS number 17344-99-9, is an organic compound that belongs to the class of amino acid esters. It is derived from alanine, an α-amino acid, where the carboxyl group is esterified with ethanol. This compound typically appears as a colorless to pale yellow liquid and is characterized by its pleasant odor. Alanine, ethyl ester is soluble in organic solvents such as ethanol and ether, but it has limited solubility in water due to its hydrophobic ethyl group. It is often used in biochemical research and as a building block in peptide synthesis. The compound exhibits properties typical of amino acids, including the ability to participate in various chemical reactions, such as esterification and transamination. Additionally, it may have applications in pharmaceuticals and as a flavoring agent in food products. Safety data should be consulted for handling and storage, as with any chemical substance.

Alanine, ethyl ester (9CI)

17344-99-9: Alanine, ethyl ester (9CI), with the CAS number 17344-99-9, is an organic compound that belongs to the class of amino acid esters. It is derived from alanine, an α-amino acid, where the carboxyl group is esterified with ethanol. This compound typically appears as a colorless to pale yellow liquid and is characterized by its pleasant odor. Alanine, ethyl ester is soluble in organic solvents such as ethanol and ether, but it has limited solubility in water due to its hydrophobic ethyl group. It is often used in biochemical research and as a building block in peptide synthesis. The compound exhibits properties typical of amino acids, including the ability to participate in various chemical reactions, such as esterification and transamination. Additionally, it may have applications in pharmaceuticals and as a flavoring agent in food products. Safety data should be consulted for handling and storage, as with any chemical substance.

H-DL-Ala-OEt · HCl

Ethyl 2-aminopropanoate

<p>H-DL-Ala-OEt·HCl (Dabigatran) is a quinolizidine alkaloid that is used in the treatment of patients with atrial fibrillation. It has been shown to inhibit the activity of the enzyme amine oxidase, which converts l-arginine to l-glutamic acid. Dabigatran etexilate, an ester prodrug of dabigatran, is hydrolyzed by esterases in blood plasma to release dabigatran, which then blocks the conversion of l-arginine to l-glutamic acid. This inhibition leads to a decrease in platelet aggregation and thrombin formation and thereby reduces blood clotting. Dabigatran etexilate also binds to primary amines on proteins such as albumin and α1-acid glycoprotein. This binding prevents the binding of other drugs such as warfarin or cl</p>

CAS 17344-99-9

Alanine, ethyl ester (9CI)

H-DL-Ala-OEt · HCl

Ref: 01-4011110

Ethyl 2-aminopropanoate

Ref: IN-DA001YWT

H-DL-Ala-OEt·HCl

Ref: 3D-FA107888